Posted by ed_uk2010 on January 31, 2012, at 8:49:59
In reply to Re: EMA Calls For W/D Market Mepbrobamate In All Anxie, posted by SLS on January 21, 2012, at 5:27:01
It's very rarely used here anyway. It would be more sensible for the EMA to simply forget about it and concentrate on the safety of drugs which are actually prescribed to more than a handful of patients.
Genus sell meprobamate in the UK. Sales are extremely low but they keep it on the market by selling at a high price. A few 'old ladies' still take it. The major effect of removing it from the market will be to cause disruption and distress to those who are dependent on it. No new patients are prescribed meprobamate here and carisoprodol (Soma, Carisoma) was discontinued years ago. This is truly a pointless move by the EMA. I suppose doctors will transfer most patients on to a low dose of diazepam.
> > I don't get it. What's the big deal? I mean, if I was a doctor, I wouldn't give elderly and/or overmedicated people meprobamate, just because its sedating and not as "clean" as benzos. But ban it? Really?
>
> I hate to see tools disappear.
>
> I don't know enough about meprobamate to place a medical value on it, but it seems to be used often enough to motivate drug companies to keep making it. Mother's Little Helper?
>
>
> - Scott
poster:ed_uk2010
thread:1007917
URL: http://www.dr-bob.org/babble/20120120/msgs/1008881.html